Supernus Pharmaceuticals (SUPN) Revenue Growth (3y) (2014 - 2025)
Supernus Pharmaceuticals (SUPN) Revenue Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 2.94% |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.13% |
| Sep 30, 2025 | 2.70% |
| Jun 30, 2025 | -0.91% |
| Mar 31, 2025 | -0.59% |
| Dec 31, 2024 | 3.07% |
| Sep 30, 2024 | 5.77% |
| Jun 30, 2024 | 6.00% |
| Mar 31, 2024 | 3.14% |
| Dec 31, 2023 | 4.60% |
| Sep 30, 2023 | -0.27% |
| Mar 31, 2023 | 17.42% |
| Dec 31, 2022 | 18.54% |
| Sep 30, 2022 | 20.19% |
| Jun 30, 2022 | 17.55% |
| Mar 31, 2022 | 21.29% |
| Dec 31, 2021 | 11.12% |
| Sep 30, 2021 | 12.96% |
| Jun 30, 2021 | 12.40% |
| Mar 31, 2021 | 13.13% |
| Dec 31, 2020 | 17.53% |